Glaxo prevails in the Canadian Federal Court of Appeal
August 02, 2010
GlaxoSmithKline Canada has won its appeal against a 2008 judgment by the Tax Court of Canada that it paid a Swiss related party too much money for the active ingredient in Zantac.
Losing the case could have cost the company millions in back taxes and penalties.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.